Impaired binding of perforin on the surface of tumor cells is a cause of target cell resistance against cytotoxic effector cells

Blood

Volumn 96, Issue 2, 2000, Pages 594-600

  Lehmann, Christof ^a,b   Zeis, Matthias ^a   Schmitz, Norbert ^a   Uharek, Lutz ^a  

^a UNIVERSITY OF KIEL   (Germany)

^b UNIVERSITY OF LEIPZIG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

PERFORIN; STREPTOLYSIN O;

ACUTE GRANULOCYTIC LEUKEMIA; ARTICLE; CELL PROTECTION; CELL STRAIN K 562; CONTROLLED STUDY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNITY; LEUKEMIA CELL LINE; NATURAL KILLER CELL; PRIORITY JOURNAL;

EID: 0034661878     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v96.2.594     Document Type: Article

References (42)

1. Champlin R, Giralt S, Gajewski J. T cells, graft-versus-host disease and graft-versus-leukemia: innovative approaches for blood and marrow transplantation. Acta Haematol. 1996;95:157.
2. Zeis M, Uharek L, Glass B, et al. Allogeneic MHC-mismatched activated natural killer cells administered after bone marrow transplantation provide a strong graft-versus-leukaemia effect in mice. Br J Haematol. 1997;96:757.
3. Zeis M, Uharek L, Glass B, et al. Allogeneic NK cells as potent antileukemic effector cells after allogeneic bone marrow transplantation in mice. Transplantation. 1995;59:1734.
4. Kolb HJ, Schattenberg A, Goldman JM, et al. Graft-versus-leukemia effect of donor lymphocyte transfusions in marrow grafted patients. European Group for Blood and Marrow Transplantation Working Party Chronic Leukemia. Blood. 1995;86:2041.
5. Hauch M, Gazzola MV, Small T, et al. Anti-leukemia potential of interteukin-2 activated natural killer cells after bone marrow transplantation for chronic myelogenous leukemia. Blood. 1990;75: 2250.
6. Karre K, Ljunggren HG, Piontek G, Klessling R. Selective rejection of H-s-deficient lymphoma variants suggests alternative immune defense strategy. Nature. 1986;319:675.
7. Lanier LL, Corliss B, Phillips JH. Arousal and inhibition of human NK cells. Immunol Rev. 1997; 155:145.
8. Shimizu Y, DeMars R. Demonstration by class I gene transfer that reduced susceptibility of human cells to natural killer cell-mediated lysis is inversely correlated with HLA class I antigen expression. Eur J Immunol. 1989;19:447.
9. Backer JC, Dummer R, Hartmann AA, Burg G, Schmidt RE. Shedding of ICAM-1 from human melanoma cell lines induced by IFN-gamma and tumor necrosis factor-alpha. Functional consequences on cell-mediated cytotoxicity. J Immunol. 1991;147:4398.
10. Shresta S, Pham CTN, Thomas DA, Graubert TA, Ley TJ. How do cytotoxic lymphocytes kill their targets? Curr Opin Immunol. 1998;10:581.
11. Berke G. The CTL's kiss of death. Cell. 1995;81:9.
12. Henkart PA. Lymphocyte-mediated cytotoxicity: two pathways and multiple effector molecules. Immunity. 1994;1:343.
13. Arase H, Arase N, Salto T. Fas-mediated cytotoxicity by freshly isolated natural killer cells. J Exp Med. 1995;181:1235.
14. French LE, Tschopp J. The TRAIL to selective tumor death. Nat Med. 1999;5:146.
15. Berke G. The Fas-based mechanism of lympho-cytotoxicity. Hum Immunol. 1997;54:1.
16. Mori S, Jewett A, Murakami-Mori K, Cavalcanti M, Bonavida B. The participation of the Fas-mediated cytotoxic pathway by natural killer cells is tumor-cell-dependent. Cancer Immunol Immunother. 1997;44:282.
17. Sayers TJ, Brooks AD, Lee JK, et al. Molecular mechanisms of immune-mediated lysis of murine renal cancer: differential contributions of perforin-dependent versus Fas-mediated pathways in lysis by NK and T cells. J Immunol. 1998;161:3957.
18. Smyth MJ, Thia KY, Cretney E, et al. Perforin is a major contributor to NK cell control of tumor metastasis. J Immunol. 1999;162:6658.
19. Young JD, Hengartner H, Podack ER, Cohn ZA. Purification and characterization of a cytolytic pore-forming protein from granules of cloned lymphocytes with natural killer activity. Cell. 1986;44: 849.
20. Vujanovic NL, Nagashima S, Herberman RB, Whiteside TL. Nonsecretory apoptotic killing by human NK cells. J Immunol. 1996;157:1117.
21. Ishiura S, Malsuda K, Koizumi H, Tsukahara T, Arahata K,Sugita H. Calcium is essential for both the membrane binding and lytic activity of pore-forming protein (perforin) from cytotoxic T-lymphocyte. Mol Immunol. 1990;27:803.
22. Gorman K, Liu CC, Blakely A, Young JD, Torbett BE, Clark WT. Cloned cytotoxic T lymphocytes as target cells. II. Polarity of lysis revisited. J Immunol. 1988;141:2211.
23. Verret CR, Firmenich AA, Kranz DM, Eisen HN. Resistance of cytotoxic T lymphocytes to the lytic effects of their toxic granules. J Exp Med. 1987; 166:1536.
24. Blakely A, Gorman K, Ostergaard H, et al. Resistance of cloned cytotoxic T lymphocytes to cell-mediated cytotoxicity. J Exp Med. 1987;166:1970.
25. Shinkai Y, Ishikawa H, Hattori M, Okumara K. Resistance of mouse cytolytic cells to pore-forming protein-mediated cytolysis. Eur J Immunol. 1988; 18:29.
26. Ojcius DM, Jiang S, Persechini PM, Detmers PA, Young JD. Cyloplasts from cytotoxic T lymphocytes are resistant to perforin-mediated lysis. Mol Immunol. 1991;28:1011.
27. Jiang S, Ojcius DM, Persechini PM, Young JD. Resistance of lymphocytes to pertorin-mediated killing: inhibition of perforin binding activity by surface membrane proteins. J Immunol. 1990;144: 998.
28. Jiang SB, Ojcius DM, Young JD. Perforin binding to cells and lipid membranes determined by a simple competition assay. J Immunol Methods. 1990;126:29.
29. Lee RK, Spielman J, Zhao DY, Olsen KJ, Podack ER. Perforin, Fas ligand, and tumor necrosis factor are the major cytotoxic molecules used by lymphokine activated killer cells. J Immunol. 1996;157:1919.
30. Lehmann C, Glass B, Zeis M, Schmitz N, Uharek L. Investigating the lysis of small cell lung cancer cell lines by activated natural killer (NK) cells with a fluorometric assay for NK-cell-mediated cytotoxicity. Cancer Immunol Immunother. 1999;48: 209.
31. Simon MM, Hausmann M, Tran T, et al. In vitro-and ex vivo-derived cytolytic leukocytes from granzyme A × B double knockout mice are defective in granule-mediated apoptosis but not lysis of target cells. J Exp Med. 1997;186:1781.
32. Duke RC, Persechini PM, Chang S, Liu CC, Cohen JJ, Young JD. Purified perforin induces target cell lysis but not DNA fragmentation. J Exp Med. 1989;170:1451.
33. Froehlich CJ, Dixit VM, Yang X. Lymphocyte granule-mediated apoptosis: matters of viral mimicry and deadly proteases. Immunol Today. 1998; 19:30.
34. Shi L, Kraut RP, Aebersold R. Greenberg AH. A natural killer cell granule protein that induces DNA fragmentation and apoptosis. J Exp Med. 1992;175:553.
35. Shresta S, Graubert TA, Thomas DA, Raptis SZ, Ley TJ. Granzyme A initiates an alternative pathway for granule-mediated apoptosis. Immunity. 1999;10:595.
36. Muller-Eberhard HJ. The membrane attack complex of complement. Annu Rev Immunol. 1986;4: 503.
37. Bhakdi S, Tranum-Jensen J. Damage to cell membrane by pore-forming bacterial cytolysins. Prog Allergy. 1988;40:1.
38. Muller C, Tschopp J. Resistance of CTL to perforin-mediated lysis. Evidence for a lymphocyte membrane protein interacting with perforin. J Immunol. 1994;153:2470.
39. +-dependent receptor molecule for lymphocyte perforin. Nature. 1989;337:272.
40. Antia R, Schlegel RA, Williamson P. Binding of perforin to membranes is sensitive to lipid spacing and not headgroup. Immunol Lett. 1992;32: 153.
41. Ojcius DM, Muller S, Hasselkus-Light C. Plasma membrane-associated proteins with the ability to partially inhibit perforin-mediated lysis. Immunol Lett. 1991;28:101.
42. Liu CC, Jiang S, Persechini PM, Zychlinsky A, Kaufmann Y, Young JD. Resistance of cytolytic lymphocytes to perforin-mediated killing. Induction of resistance correlates with increase in cytotoxicity. J Exp Med. 1989;169:2211.